The neutrophil-lymphocyte ratio and immunosuppressive acidic protein may be useful parameters for predicting depression among middle-aged patients with diffuse large B cell lymphoma

نویسندگان

چکیده

Background Patients with diffuse large B cell lymphoma (DLBCL) may experience depression. Growing evidence shows that depression interacts immunity. However, the relationship between and immunity among DLBCL patients has not been investigated, despite reports indicating often suffer from Methods To accurately investigate immunity, 82 primarily diagnosed middle-aged who received standard chemotherapy were enrolled. The divided into depressed nondepressed groups according to Zung Self-rating Depression Scale (SDS) scores. Prozac was used treat until their symptoms alleviated. concentration of immunosuppressive acidic protein (IAP); percentages cluster differentiation (CD)3+, CD4+, CD8+ T lymphocytes CD56+ natural killer (NK) cells; absolute lymphocyte count (ALC); neutrophil--lymphocyte ratio (NLR) calculated at enrollment after treatment. Results A higher score on test positively associated serum IAP levels NLR, negatively ALC. NLR in significantly compared those patients. Conclusions Our results suggest for first time are closely correlated be parameters predicting

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis

BACKGROUND Neutrophil-to-lymphocyte ratio (NLR) has been investigated as a prognostic marker in patients with diffuse large B-cell lymphoma (DLBCL); however, the results remain controversial. This study aimed to explore the association between NLR and survival outcomes and clinicopathological factors in DLBCL. METHODS Relevant studies were retrieved by searching PubMed, Embase, Web of Science...

متن کامل

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP

This study aims to investigate whether neutrophil to lymphocyte ratio (NLR) is an independent predictor in newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients in the rituximab era. Data from newly diagnosed DLBCL patients at Nanjing Drum Tower Hospital from 2006 to 2015 were retrospectively reviewed. We used the receiver operating characteristic (ROC) curve analysis to generate the o...

متن کامل

Measurement of pyruvate dehydrogenase enzyme in patients with diffuse large B-cell lymphoma relapse

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL), which is the most common type of lymphoma. NHL comprises a group of clinically and biologically diverse diseases, which range from indolent to aggressive clinical courses. Despite treatment advances in the last three decades with the use of combination immunotherapy, a significant fraction...

متن کامل

Prognostic Significance of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP

Recently, as studies on the relationship between cancer and inflammation have increased, interest in the association between the degree of inflammation associated with a tumor and the cancer prognosis has increased. Since inflammation provides biomolecular substances such as growth factors in the microenvironment surrounding the tumor, it facilitates proliferation, angiogenesis, invasion and me...

متن کامل

miR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. MicroRNAs (miRNAs) are endogenous small RNA, which can regulate gene expression at the post-transcriptional level. MiRNA profiling has shown a great potential as novel diagnostic and prognostic biomarkers. The present study was performed at the Nemazee Teaching Hospital (Shiraz, Iran) from 2011 to 2013.The aim of thi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of palliative medicine

سال: 2021

ISSN: ['2224-5839', '2224-5820']

DOI: https://doi.org/10.21037/apm-21-601